期刊文献+

非小细胞肺癌患者外周血淋巴结和肺癌组织中血管内皮生长因子C表达的相关性研究 被引量:3

原文传递
导出
摘要 非小细胞肺癌(NSCLC)约占全部肺癌的80%~85%,局部复发和转移是其治疗失败的主要原因之一。血管内皮生长因子C(VEGF-C)具有刺激血管和淋巴管生成的双重作用,其表达与肿瘤的血管和淋巴管生成及转移有关。我们探讨了VEGF—C在NSCLC患者外周血、淋巴结和肺癌组织中的表达水平和相关忤,及其与患者临床病理特征的关系,现将结果报告如下。
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2011年第7期527-528,共2页 Chinese Journal of Oncology
基金 基金项目:山东省医药卫生科技攻关项目(2007HW137)
  • 相关文献

参考文献4

二级参考文献29

  • 1何振平.胆囊癌的临床特征及外科治疗[J].现代医药卫生,2004,20(18):1829-1830. 被引量:3
  • 2Joukov V, Pajusola K, KaiPainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 ( VEGFR-3 ) and KDR ( VEGFR-2 ) receptor tyrosine kinases. EMBO J, 1996, 15: 290-298.
  • 3Tanaka K, Kurebayashi J, Sonoo H, et al. Expression of vascular endothelial growth factor family messenger RNA in diseased thyroid tissues. Surg Today, 2002, 32: 761-768.
  • 4Fromowitz FB, Viola MV, Chao S, et al. ras p21 expression in the progression of breast cancer. Hum Pathol, 1987, 18: 1268- 1275.
  • 5Takizawa H, Kondo K, Fujino H, et al. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer. Br J Cancer, 2006, 95 : 75-79.
  • 6Kojima H, Shijubo N, Yamada G, et al. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma. Cancer, 2005, 104: 1668-1677.
  • 7Saintigny P, Kambouchner M, Ly M, et al. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node. Lung Cancer, 2007, 58: 205-213.
  • 8Ogawa E, Takenaka K, Yanagihara K, et al. Clinical significance of VEGF-C status in tumour cells and stromal macrophages in nonsmall cell lung cancer patients. Br J Cancer, 2004, 91 : 498-503.
  • 9Timoshenko AV, Chakraborty C, Wagner GF, et al. COX-2- mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer, 2006, 94 : 1154-1163.
  • 10Oh SJ, Jeltsch MM, Birkenhager R, et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol, 1997, 188 : 96-109.

共引文献31

同被引文献36

  • 1Nichols C,Laster LL,Bodak Gyovai LZ. Diabetes mellitus and periodontal disease[J].{H}Journal of Periodontology,1978,(2):85-88.
  • 2Pittenger MF,Mackay AM,Beck SC. Multilineage potential of adult human mesenchymal stem cells[J].{H}SCIENCE,1999,(5411):143-147.
  • 3ProckOp DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues[J].{H}SCIENCE,1997,(5309):71-74.
  • 4evans MJ,Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos[J].{H}NATURE,1981,(5819):154-156.
  • 5Hong SQ,Zhang HT,You J. Comparison of transdifferentiated and untransdifferentiated human umbilical mesenchymal stem cells in rats after traumatic brain injury[J].{H}Neurochemical Research,2011,(12):2391-2400.
  • 6Zanier ER,Montinaro M,Vigano M. Human umbilical cord blood mesenchymal stem ceils protect mice brain after trauma[J].{H}CRITICAL CARE MEDICINE,2011,(11):2501-2510.
  • 7Lim JY,Jeong CH,Jun JA. Therapeutic effects of human umbilical cord blood derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia[J].Stem Cell Res Ther,2011,(5):38.
  • 8Lin YC,Ko TL,Shih YH. Human umbilical mesenchymal stem cells promote recovery after ischemic stroke[J].{H}STROKE,2011,(7):2045-2053.
  • 9Lee JH,Chung WH,Kang EH. Schwann cell-like remyelination following transplantation of humanumbilicalcord blood (hUCB)-derived mesenchymal stem cells in dogs with acute spinal cord injury[J].{H}Journal of the Neurological Sciences,2011,(1-2):86-96.
  • 10Le Guelte A,Dwyer J,Gavard J. Jumping the barrier:VEcadherin,VEGF and other angiogenic modifiers in cancer[J].{H}Biologie Cellulaire,2011,(12):593-605.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部